Tevfik Kalelioglu1, Abdullah Genc2, Nesrin Karamustafalioglu1. 1. Department of Psychiatry, Bakırköy Mental Health Research and Teaching Hospital, Istanbul, Turkey. 2. Department of Psychiatry, Sisli Hamidiye Etfal Research and Teaching Hospital, Istanbul, Turkey.
TO THE EDITORWe recently read with interest the article by Şenyurt et al. titled “Evaluation of Oxidative Status in Patients Treated with Electroconvulsive Therapy” published in February 2017 in this journal.1) The authors conducted a study suggesting that electroconvulsive therapy (ECT) has no negative effect on oxidative stress in terms of serum total oxidant status (TOS), total antioxidant status (TAS) and their ratio oxidative stress index (OSI). Even though the sub-groups have small sample size which may be inadequate for a statistically significance, they found that OSI levels were decreased significantly in schizophrenia, insignificantly in bipolar and major depressive groups after ECT when compared with pre-ECT levels.1)We would like to comment on this research. Despite the fact that this study has negative trial results which is also negative factor for publishing, we believe that it contributes valuable information as important as positive results in the growing evidence of the relation between ECT and oxidative stress. There are a limited number of clinical studies about effect of ECT on oxidative mechanisms.2–4) Besides evaluating the oxidant-antioxidant molecules individually, evaluating the total oxidant and antioxidant capacity may have a potential to reflect the status of whole system homeostasis. Hence, we think that this study has an advantage to reflect such an association between ECT and oxidative homeostasis.Antipsychotics are important therapeutic agents used in treatment of schizophrenia, bipolar disorder and also major depressive disorder. The authors state that the anti-psychotics have positive effects on oxidative stress. However, on contrary, preclinical and in-vitro studies demonstrate increased oxidative stress particularly with typical antipsychotics.5–7) Furthermore, in our previously published study, we evaluated serum TAS, TOS and OSI levels in manic state and alterations with the treatment modalities of ECT+antipsychotics or antipsychotics alone. Strikingly we have found that only antipsychotic group showed a significant increase in OSI levels whereas no significant change was observed in ECT+ antipsychotic group in terms of oxidative stress. As similar to above-mentioned studies, clinically we demonstrated that anti-psychotics might increase oxidative burden.8)Taken together, in concordance with the current study performed by Şenyurt et al.,1) our previous study has indicated that ECT may have positive or at least no additional influences on oxidative stress. Studies with larger samples and refined groups from effect of confounders are required to confirm these findings.
Authors: Tevfik Kalelioglu; Abdullah Genc; Nesrin Karamustafalioglu; Akif Tasdemir; Ferda Can Gungor; Alparslan Cansiz; Said Incir; M Cem Ilnem; Murat Emul Journal: Psychiatry Res Date: 2014-04-16 Impact factor: 3.222
Authors: Abdullah Genc; Tevfik Kalelioglu; Nesrin Karamustafalioglu; Akif Tasdemir; Ferda Can Gungor; Esra Sena Genc; Said Incir; Cem Ilnem; Murat Emul Journal: Psychiatry Clin Neurosci Date: 2014-11-14 Impact factor: 5.188
Authors: Anders Jorgensen; Jesper Krogh; Kamilla Miskowiak; Tom G Bolwig; Lars V Kessing; Anders Fink-Jensen; Merete Nordentoft; Trine Henriksen; Allan Weimann; Henrik E Poulsen; Martin B Jorgensen Journal: J Affect Disord Date: 2013-03-13 Impact factor: 4.839
Authors: Martina Raudenska; Jaromir Gumulec; Petr Babula; Tibor Stracina; Marketa Sztalmachova; Hana Polanska; Vojtech Adam; Rene Kizek; Marie Novakova; Michal Masarik Journal: Mini Rev Med Chem Date: 2013-12 Impact factor: 3.862